Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options

doi:10.3748/wjg.v22.i22.5285

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6288)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

615

WORD

230

HTML

2946

Figures (1-2)

167

Tables (1-1)

144

Sum=4102

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

971

Download

1215

Sum=2186

Jun 14, 2016 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Jun 14, 2016; 22(22): 5285-5292
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5285

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow chart of studies screened and included in meta-analysis. ¹Two studies included in two different sub-meta-analysis. SOF: Sofosbuvir; DCV: Daclatasvir; LDV: Ledipasvir; PEG-IFN: Polyethylene glycol interferon.

Open in New Tab Full Size Figure Download Figure

Figure 2 Odds ratio (95%CI) and Forest plot for SVR rates. A: SOF + RBV + PEG-IFN vs SOF + RBV combinations; B: SOF + RBV 12 wk/16 wk vs SOF + RBV 24 wk combinations; C: SOF + RBV 12 wk/16 wk vs SOF + RBV 24 wk combinations; D: SOF + LDV vs SOF + LDV + RBV combinations.

Citation: Ampuero J, Reddy KR, Romero-Gomez M. Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options. World J Gastroenterol 2016; 22(22): 5285-5292
URL: https://www.wjgnet.com/1007-9327/full/v22/i22/5285.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i22.5285